Novocure
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $193,399 | $183,584 | $174,055 | $174,350 |
Gross Profit | 148,870 | 142,478 | 135,126 | 132,193 |
EBITDA | 2,080 | -6,255 | -63,296 | -36,736 |
EBIT | -2,336 | -10,562 | -67,420 | -40,954 |
Net Income | -10,435 | -15,658 | -71,138 | -24,499 |
Net Change In Cash | 193,399 | 183,584 | 174,055 | 174,350 |
Free Cash Flow | 15,746 | 5,525 | -18,669 | -22,900 |
Cash | 96,734 | 93,701 | 97,324 | 103,390 |
Basic Shares | 116,785 | 116,012 | 114,149 | 111,471 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $655,353 | $605,220 | $509,338 | $537,840 |
Gross Profit | 488,474 | 468,039 | 381,058 | 422,973 |
EBITDA | -121,600 | -109,584 | -177,452 | -78,899 |
EBIT | -136,250 | -120,819 | -188,421 | -89,523 |
Net Income | -136,227 | -168,627 | -207,043 | -92,534 |
Net Change In Cash | 655,353 | 605,220 | 509,338 | 537,840 |
Cost of Revenue | -93,678 | |||
Free Cash Flow | -75,679 | -69,224 | -100,429 | 9,430 |
Cash | 103,390 | 163,767 | 240,821 | 115,326 |
Basic Shares | 111,471 | 107,834 | 106,391 | 104,660 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.09 |
2026-06-30 | -$0.13 |
2026-03-31 | -$0.62 |
2025-12-31 | -$0.22 |